Autoimmune thrombocytopenic purpura (AITP) and acquired thrombasthenia due to autoantibodies to GP IIb–IIIa in a patient with an unusual platelet membrane glycoprotein composition
Authors:
Open Access
- 1 February 1998
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 57 (2) , 164-175
Abstract
The subject (E.B.) is a 63‐year‐old woman with autoimmune thrombocytopenic purpura (AITP) who was first examined some 6 years ago with symptoms of epistaxis and gum bleeding, severe thrombocytopenia, and large platelets. Her serum tested positively with control platelets in the MAIPA assay performed using monoclonal antibodies (MoAb) to glycoprotein (GP) IIIa (XIIF9, Y2/51), yet was negative in the presence of MoAbs to GP IIb (SZ 22) or to the GP IIb‐IIIa complex (AP2, P2). The patient's platelets failed to aggregate with all agonists tested except for ristocetin. IgG isolated from the patient's serum inhibited ADP‐induced aggregation of control platelets. Unexpectedly, flow cytometry showed an altered expression of membrane glycoproteins on the patient's platelets. Levels of GP Ib‐IX were much higher than previously located by us in platelets. In contrast, the expression of GP IIb‐IIIa was about half that seen with control subjects. When Western blotting was performed, a striking finding was a strong band of 250 kDa recognized by a series of MoAbs to GP Ibα in addition to the band in the normal position of GP Ibα. Finally, ADP‐stimulated (E.B.) platelets failed to express activation‐dependent epitopes on GP IIb‐IIIa as recognized by PAC‐1, AP6, or F26 and additionally gave a reduced P‐selectin expression after thrombin addition. In conclusion, we present a novel patient with a severely perturbed platelet function where an altered membrane GP profile is associated with the presence of an autoantibody recognizing a complex‐dependent determinant on GP IIb–IIIa and inhibitory of platelet aggregation. Am. J. Hematol. 57:164–175, 1998.Keywords
This publication has 31 references indexed in Scilit:
- AUTOANTIBODIES AND ANTI‐MOUSE ANTIBODIES IN THROMBOCYTOPENIC PATIENTS AS ASSESSed by DIFFERENT MAIPA assaysBritish Journal of Haematology, 1996
- Outside-in Integrin Signal TransductionJournal of Biological Chemistry, 1996
- A Patient with Autoimmune Thrombocytopenic Purpura Demonstrating Serum Antibodies Reactive with Mouse Cross-Reactive IdiotypesClinical Immunology and Immunopathology, 1995
- Flow cytometry reveals activated GP IIb???IIIa complexes on platelets from patients undergoing thrombolytic therapy after acute myocardial infarctionBlood Coagulation & Fibrinolysis, 1995
- Endogenous platelet fibrinogen: its modulation after surface expression is related to size‐selective access to and conformational changes in the bound fibrinogenBritish Journal of Haematology, 1992
- Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpuraBritish Journal of Haematology, 1991
- Demonstration of platelet antigens that bind platelet-associated autoantibodies in chronic ITP by direct immunoprecipitation procedureBritish Journal of Haematology, 1990
- A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder.Journal of Clinical Investigation, 1986
- Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias.Journal of Clinical Investigation, 1984
- Thromboxane Synthesis and the Platelet Release Reaction in Bernard‐Soulier Syndrome, Thrombasthenia Glanzmann and Hermansky‐Pudlak SyndromeBritish Journal of Haematology, 1977